Filing Details

Accession Number:
0001829126-23-004521
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-30 16:05:14
Reporting Period:
2023-06-28
Accepted Time:
2023-06-30 16:05:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1557376 Organicell Regenerative Medicine Inc. OCEL Biological Products, (No Disgnostic Substances) (2836) 474180540
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1888273 L. Harry Leider 3321 College Avenue
Suite 246
Davie FL 33314
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-06-28 549,450 $0.10 549,450 No 4 P Indirect See footnote
Common Stock Acquisiton 2023-06-29 500,000 $0.01 1,049,450 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
No 4 P Indirect See footnote
Footnotes
  1. The shares are held by the Harry L. Leider Revocable Trust of which the Reporting Person is the Trustee.